Delivery Order SPE2DB24D1034-SPE2DB25FWCB3

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,089.80, is for the supply of Cosentyx (300mg dose) medication. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,707.33 firm-fixed-price contract is for the delivery of Cosentyx, a medication used to treat certain autoimmune conditions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $30,527.97 firm fixed-price delivery order is for the drug Cosentyx, a medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,951.95, is for the supply of the medication Cosentyx (300 mg dose) and has a period of performance through April 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Cosentyx, a specialty medication for the treatment of various medical conditions. The $7,910.36 firm fixed-price contract has a completion date of February 4, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,927.41, is for the delivery of the prescription medication Cosentyx, a treatment for autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,205.68, is for the delivery of Cosentyx, a biologic medication used to treat certain autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $136,703.03 fixed-price contract is for the supply of Cosentyx (300mg dose) through May 2, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a broad vehicle for the company to supply pharmaceuticals and medical supplies to support military healthcare programs...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for Cosentyx, a specialty medication. The contract is a $25,716.41 firm fixed-price delivery order with a completion date of July 16, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,377.62, is for the supply of Cosentyx (300 mg) medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. The contract is not set-aside and was open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWCB3
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,205.33 firm-fixed-price contract is for the supply of Cosentyx, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/15/25, 3:43 PM